James Snider
President bij Critical Care Diagnostics, Inc.
Profiel
James V.
Snider is currently the President, Chief Scientific Officer & Director at Critical Care Diagnostics, Inc. He is also currently serving as the Treasurer & Director at JCC Greater Boston.
Previously, he worked as an Advisory Board Member at Embark Healthcare, a Principal at Intelligent Medical Devices, Inc., and a Principal at Applied Biosystems, Inc. Dr. Snider completed his undergraduate degree at Grand Valley State University (Michigan), his MBA at the University of Phoenix, and his doctorate at the University of South Carolina.
Actieve functies van James Snider
| Bedrijven | Functie | Begin |
|---|---|---|
Critical Care Diagnostics, Inc.
 Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | President | - |
| Jcc Greater Boston | Director/Board Member | - |
Eerdere bekende functies van James Snider
| Bedrijven | Functie | Einde |
|---|---|---|
Intelligent Medical Devices, Inc.
 Intelligent Medical Devices, Inc. Pharmaceuticals: MajorHealth Technology Intelligent Medical Devices, Inc. engages in the designs development and manufacture of platform-agnostic, regulatory-cleared molecular diagnostic tests. The company was founded by Alice A. Jacobs Nesselrodt in 2000 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Corporate Officer/Principal | - |
Embark Healthcare
 Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Corporate Officer/Principal | - |
Opleiding van James Snider
| Grand Valley State University (Michigan) | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
| University of South Carolina | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Embark Healthcare
Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Finance |
Intelligent Medical Devices, Inc.
Intelligent Medical Devices, Inc. Pharmaceuticals: MajorHealth Technology Intelligent Medical Devices, Inc. engages in the designs development and manufacture of platform-agnostic, regulatory-cleared molecular diagnostic tests. The company was founded by Alice A. Jacobs Nesselrodt in 2000 and is headquartered in Waltham, MA. | Health Technology |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
Critical Care Diagnostics, Inc.
Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Health Technology |
| Jcc Greater Boston |
